Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

OneTouch Verio glucose meters recalled

The manufacturer of the OneTouch® Verio® IQ and OneTouch® Verio® Pro blood glucose testing meters have written to healthcare professionals advising that these meters either fail to provide a warning or provide an incorrect result when blood glucose levels are very high. As a result users of both meters are being advised to access a replacement meter.

In the case of the IQ meter, when glucose levels are 56.8mmol/L or above the meter will turn off instead of displaying a message warning the user that their glucose level is extremely high. In the case of the Pro meter, when glucose levels are 56.8mmol/L or above the meter will display an inaccurate reading that is the difference between the actual level and 56.8mmol/L. For example, if the real level is 59.1mmol/L the display would read 2.3mmol/L (59.1-56.8 = 2.3).

Patients can be advised to call 0800 279 9118 to access a replacement meter. Both affected meters use the OneTouch Verio testing strip so it might be prudent to identify patients who are prescribed these strips and advise them accordingly.

Action: Clinicians should be aware of this issue and advise affected patients of the need to obtain a replacement meter.

Share 'OneTouch Verio glucose meters recalled' on Email Share 'OneTouch Verio glucose meters recalled' on Delicious Share 'OneTouch Verio glucose meters recalled' on Digg Share 'OneTouch Verio glucose meters recalled' on Facebook Share 'OneTouch Verio glucose meters recalled' on reddit Share 'OneTouch Verio glucose meters recalled' on StumbleUpon Share 'OneTouch Verio glucose meters recalled' on Twitter

QOF 2013-14

The turn of the financial year brings into effect several changes to the Quality and Outcomes Framework (QOF). The changes are available in summarised form and there is also a detailed document.

Particular areas of change are:

  • Introduction of a new rheumatoid arthritis clinical domain
  • Patients with hypertension with elevated cardiovascular risk should be prescribed a statin
  • Younger hypertensive patients have a tighter blood pressure target
  • Newly diagnosed diabetics should be referred to an education programme
  • Men with diabetes should be assessed for erectile dysfunction
  • Pulse oximetry should be assessed in COPD patients with an MRC dyspnoea score of 3 or more
  • Cancer care reviews must be completed within 3 months of diagnosis
  • Depression requires a bio-psychosocial assessment at diagnosis and again at 10-35 days after diagnosis
  • 15 month review windows have been reduced to 12 months
  • Many payment thresholds have been raised

Action: Clinicians should be aware of these changes and make any necessary changes to clinical practice as soon as possible.

Share 'QOF 2013-14' on Email Share 'QOF 2013-14' on Delicious Share 'QOF 2013-14' on Digg Share 'QOF 2013-14' on Facebook Share 'QOF 2013-14' on reddit Share 'QOF 2013-14' on StumbleUpon Share 'QOF 2013-14' on Twitter

Newer Posts »

Prescribing Advice for GPs is powered by ClassicPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer